Genprex (GNPX) Net Income (2016 - 2025)
Genprex (GNPX) posted quarterly Net Income of -$693150.0 for Q1 2025, up 88.46% year-over-year from -$367797.3 in Q1 2024, and up 83.59% quarter-over-quarter from -$4.2 million in Q4 2024.
Genprex (GNPX) Net Income (2016 - 2025) Analysis & Trends
Genprex's Net Income history runs 10 years deep, the most recent figure standing at -$693150.0 for Q1 2025.
- In Q1 2025, Net Income rose 88.46% year-over-year to -$693150.0; the TTM figure through Dec 2025 stood at -$693150.0 (up 96.72% YoY), while the FY2025 annual figure was -$46.1 million, up 5.33% from the prior year.
- Net Income for Q1 2025 stood at -$693150.0, up from -$4.2 million in the prior quarter.
- The five-year high for Net Income was -$693150.0 in Q1 2025, with the low at -$9.3 million in Q1 2023.
- The 5-year median for Net Income is -$5.9 million (2023), against an average of -$5.7 million.
- The sharpest annual moves came in 2022 and 2025: Net Income slumped 79.42% in 2022, then jumped 88.46% in 2025.
- Genprex's Net Income stood at -$6.8 million in 2021, then gained by 3.03% to -$6.5 million in 2022, then rose by 9.12% to -$5.9 million in 2023, then gained by 28.98% to -$4.2 million in 2024, then jumped by 83.59% to -$693150.0 in 2025.
- Business Quant data shows GNPX's Net Income at -$693150.0 in Q1 2025, -$4.2 million in Q4 2024, and -$4.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 164.49 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -13.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -355.03 Mn |
| 10 | Genprex | 1.89 Mn | -13.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -693,150.00 |
| Dec 31, 2024 | -4.23 Mn |
| Sep 30, 2024 | -4.35 Mn |
| Jun 30, 2024 | -6.53 Mn |
| Mar 31, 2024 | -6.01 Mn |
| Dec 31, 2023 | -5.95 Mn |
| Sep 30, 2023 | -7.76 Mn |
| Jun 30, 2023 | -8.01 Mn |
| Mar 31, 2023 | -9.26 Mn |
| Dec 31, 2022 | -6.55 Mn |
| Sep 30, 2022 | -6.17 Mn |
| Jun 30, 2022 | -5.79 Mn |
| Mar 31, 2022 | -5.31 Mn |
| Dec 31, 2021 | -6.75 Mn |
| Sep 30, 2021 | -3.44 Mn |
| Jun 30, 2021 | -3.99 Mn |
| Mar 31, 2021 | -5.31 Mn |
| Dec 31, 2020 | -5.23 Mn |
| Sep 30, 2020 | -2.77 Mn |
| Jun 30, 2020 | -4.37 Mn |